A longitudinal study on parotid and submandibular gland changes assessed by magnetic resonance imaging and ultrasonography in post-radiotherapy nasopharyngeal cancer patients.

OBJECTIVES: With regard to the intensity modulated radiotherapy (IMRT) of nasopharyngeal carcinoma (NPC) patients, this longitudinal study evaluated the radiation-induced changes in the parotid and submandibular glands in terms of gland size, echogenicity and haemodynamic parameters. METHODS: 21 NPC patients treated by IMRT underwent MRI and ultrasound scans before radiotherapy, and at 6, 12, 18 and 24 months after treatment. Parotid and submandibular gland volumes were measured from the MRI images, whereas the parotid echogenicity and haemodynamic parameters including the resistive index, pulsatility index, peak systolic velocity and end diastolic velocity were evaluated by ultrasonography. Trend lines were plotted to show the pattern of changes. The correlations of gland doses and the post-RT changes were also studied. RESULTS: The volume of the parotid and submandibular glands demonstrated a significant drop from pre-RT to 6 months post-RT. The parotid gland changed from hyperechoic before RT to either isoechoic or hypoechoic after treatment. The resistive index and pulsatility index decreased from pre-RT to 6 month post-RT, then started to increase at 12 month time interval. Both peak systolic velocity and end diastolic velocity increased after 6 months post-RT then followed a decreasing trend up to 24 months post-RT. There was mild correlation between post-RT gland dose and gland volume, but not with haemodynamic changes. CONCLUSIONS: Radiation from IMRT caused shrinkage of parotid and submandibular glands in NPC patients. It also changed the echogenicity and vascular condition of the parotid gland. The most significant changes were observed at 6 months after radiotherapy. ADVANCES IN KNOWLEDGE: It is the first paper that reports on the longitudinal changes of salivary gland volume, echogenicity and haemodynamic parameters altogether in NPC patients after radiotherapy. The results are useful for the prediction of glandular changes that is associated with xerostomia, which help to provide timely management of the complication when the patients attend follow-up visits.

A study on the post-radiotherapy changes of temporomandibular joint in nasopharyngeal carcinoma patients.

OBJECTIVE: Radiation-induced trismus, which is resulted from damage of the temporomandibular joint (TMJ), is one of the common late complications in nasopharyngeal carcinoma (NPC) patients after radical radiotherapy. This study investigated the radiation induced TMJ changes using ultrasonography in post-radiotherapy (post-RT) NPC patients. METHODS: 114 NPC patients, who had completed radiotherapy for more than 4 years, were assessed with the maximum incisal distance (MID) and ultrasonography examination of TMJ from which the maximum disc thickness of the joint disc, the condyle irregularity (CI), joint vascularity (JV) and relative muscle echogenicity were assessed. The same assessments were conducted on 100 age-matched normal subjects. The results were compared among the patients with and without trismus, and the control group. The mean doses to the TMJ were estimated using the treatment planning system and their correlation with the magnitude of MID was also investigated by the Pearson correlation test. RESULTS: 39 out of the 114 patients (34.2%) presented with trismus. The average mean TMJ for all patients was 41.4 Gy, in which patients with trismus was significantly higher than patients without trismus (p = 0.017). The mean MID of patient group was significantly lower than control group (p < 0.001). The mean maximum disc thickness of the patient group was significantly smaller than the control group, whereas the mean CI and JV were significantly higher in patient group. For relative muscle echogenicity, a higher percentage of the control group showed hyperechoic pterygoid muscle than the patient group. The mean total dose to the TMJs for the patient group was 41.4 Gy and there was a mild negative correlation between the mean TMJ dose and the MID (r = -350). CONCLUSION: The TMJ in post-RT NPC patients showed reduction of disc thickness, increase of CI and JV. Patients with trismus demonstrated thinner disc thickness and higher JV than those without trismus. Advances in knowledge: Our study was the first cross-sectional comparative study involving over 100 patients and normal subjects that used ultrasound to assess the radiation-induced morphological changes of TMJ. Post-RT TMJ changes characterized by the reduction of disc thickness, increase of CI and JV were detected in the NPC patients. The parameters used in this study were able to detect the morphological differences between the patient group and control group, and therefore can be effectively used to monitor the TMJ condition of post-RT NPC patients.

Ultrasound Evaluation of Carotid Atherosclerosis in Post-Radiotherapy Nasopharyngeal Carcinoma Patients, Type 2 Diabetics, and Healthy Controls.

Purpose To comprehensively evaluate and compare the degree of carotid atherosclerosis in patients treated with radiotherapy (RT) for nasopharyngeal carcinoma (NPC) and in patients with type 2 diabetes mellitus (DM), and using healthy subjects as controls. Materials and Methods The present study recruited 69 post-RT NPC patients without conventional cardiovascular risk factors, 70 type 2 diabetic patients without previous RT, and 76 healthy controls without conventional cardiovascular risk factors and previous RT. For each participant, 5 carotid atherosclerotic parameters, namely carotid intima-media thickness (CIMT), carotid arterial stiffness (CAS), presence of carotid plaque, carotid plaque score, and presence of ≥ 50 % carotid stenosis, were assessed using ultrasonography. The differences in these carotid atherosclerotic parameters between study groups were compared using ANCOVA or logistic regression after the adjustment for age and gender. Multiple comparisons were corrected using the Benjamini-Hochberg false discovery rate. Results Post-RT NPC patients and type 2 diabetics had a significantly higher CIMT, CAS and carotid plaque burden compared to the healthy subjects (corrected P-value, Pcor < 0.05). In addition, carotid atherosclerosis in post-RT NPC patients tended to be more severe with significantly higher CAS and carotid plaque burden than that in type 2 diabetics (Pcor < 0.05). Conclusion Neck RT for NPC is an independent risk factor of carotid atherosclerosis, and radiation induces more severe carotid atherosclerosis in post-RT NPC patients. Thus, assessment of carotid atherosclerosis using ultrasonography may be necessary for these patients and should be indicated in the routine follow-up of NPC.

Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma.

BACKGROUND: Advanced inoperable hepatocellular carcinoma (HCC) conferring a grave prognosis may benefit from yttrium-90 ((90)Y) radioembolization. METHODS: Thirty patients with advanced inoperable HCC including those with any lesion >8 cm in maximal diameter or multiple bi-lobar lesions (totally more than five lesions), or portal vein thrombosis treated with radioembolization were reviewed. Treatment efficacy and safety were evaluated. Univariate and multivariate analyses were performed for identifying potential prognostic factors. RESULTS: After a median follow-up of 18.3 months, the response rate was 30.0%, and the disease control rate was 50.0%. Median overall progression-free survival (PFS) and overall survival (OS) were 3.3 months and 13.2 months, respectively. Longer median PFS was noted in those who had transarterial chemoembolization before radioembolization (7.3 months vs 3.1 months; P=0.021) and duration of alfafeto protein (AFP) response ≥6 months (11.8 months vs 3.0 months; P<0.001). Longer median OS was also revealed in those without portal vein thrombosis (17.1 months vs 4.4 months; P=0.015) and those whose duration of AFP response was ≥6 months (21.2 months vs 8.6 months; P=0.001). Seventeen patients (56.7%) developed treatment-related complications including five (16.7%) grade 3 events. Multivariate analysis revealed that treatment responders (P=0.001) and duration of AFP response ≥6 months (P=0.006) were prognostic of PFS, whereas the absence of portal vein invasion (P=0.025), treatment responders (P=0.010), and duration of AFP response ≥6 months (P=0.001) were prognostic of OS. CONCLUSION: (90)Y radioembolization is an alternative treatment with a promising outcome for poor-risk advanced inoperable HCC.